Literature DB >> 25119953

Comparative effectiveness of patient-centered strategies to improve FDA medication guides.

Michael S Wolf1, Stacy C Bailey, Marina Serper, Meredith Smith, Terry C Davis, Allison L Russell, Beenish S Manzoor, Lisa Belter, Ruth M Parker, Bruce Lambert.   

Abstract

BACKGROUND: Med Guides are the only Food and Drug Administration-regulated source of written patient information distributed with prescriptions drugs. Despite their potential value, studies have found them to have limited utility.
OBJECTIVE: To evaluate the effectiveness of patient-centered strategies for the design of Med Guides to improve comprehension.
DESIGN: A cross-sectional, randomized trial.
SETTING: Two primary care clinics in Chicago, Illinois; one based in a public university hospital and the other within a private academic medical center. PATIENTS: A total of 1003 adults aged 18-85 years. INTERVENTION: The format and layout of content from 3 typical Med Guides (by reading difficulty, length, exposure) were modified several ways to promote information accessibility. Working with patients, the 3 most preferred versions were evaluated. The first used 2 columns to organize content (Column), a second mimicked over-the-counter "Drug Facts" labeling (Drug Facts), and the third followed health literacy best practices using a simple table format (Health Literacy prototype). MEASURES: Tailored comprehension assessment of content from 3 representative Med Guides.
RESULTS: Comprehension was significantly greater for all 3 prototypes compared with the current standard (all P<0.001). The Health Literacy prototype consistently demonstrated the highest comprehension scores, and in multivariable analyses, outperformed both the Drug Facts [β=-4.43, 95% confidence interval (CI), -6.21 to -2.66] and Column (β=-4.04, 95% CI, -5.82 to -2.26) prototypes. Both older age (older than 60 y: β=-10.54, 95% CI, -15.12 to -5.96), low and marginal literacy skills were independently associated with poorer comprehension (low: β=-31.92, 95% CI, -35.72 to -28.12; marginal: β=-12.91, 95% CI, -16.01 to -9.82).
CONCLUSIONS: The application of evidence-based practices to the redesign of Med Guides significantly improved patient comprehension. Although some age and literacy disparities were reduced with the Health Literacy format in particular, both older age and low literacy remained independently associated with poorer comprehension. More aggressive strategies will likely be needed to gain assurances that all patients are informed about their prescribed medications. TRIAL REGISTRATION: Clinical Trials.Gov #NCT01731405.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25119953     DOI: 10.1097/MLR.0000000000000182

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  11 in total

Review 1.  Pharmaceutical Benefit-Risk Communication Tools: A Review of the Literature.

Authors:  Dominic Way; Hortense Blazsin; Ragnar Löfstedt; Frederic Bouder
Journal:  Drug Saf       Date:  2017-01       Impact factor: 5.606

2.  Development and rationale for a multifactorial, randomized controlled trial to test strategies to promote adherence to complex drug regimens among older adults.

Authors:  Stacy Cooper Bailey; Guisselle A Wismer; Ruth M Parker; Surrey M Walton; Alastair J J Wood; Amisha Wallia; Samantha A Brokenshire; Alexandra C Infanzon; Laura M Curtis; Mary J Kwasny; Michael S Wolf
Journal:  Contemp Clin Trials       Date:  2017-08-18       Impact factor: 2.226

3.  The electronic medication complete communication (EMC2) study: Rationale and methods for a randomized controlled trial of a strategy to promote medication safety in ambulatory care.

Authors:  Stacy Cooper Bailey; Michael K Paasche-Orlow; William G Adams; Samantha A Brokenshire; Laura A Hedlund; Ryan P Hickson; Christine U Oramasionwu; Amy L Moore; Danielle M McCarthy; Laura M Curtis; Mary J Kwasny; Michael S Wolf
Journal:  Contemp Clin Trials       Date:  2016-10-22       Impact factor: 2.226

Review 4.  Medication Risk Communication in Rheumatology: Where Are We and Where Do We Go from Here?

Authors:  Susan J Blalock
Journal:  Curr Rheumatol Rep       Date:  2017-02       Impact factor: 4.592

5.  A Multifaceted Intervention to Improve Patient Knowledge and Safe Use of Opioids: Results of the ED EMC2 Randomized Controlled Trial.

Authors:  Danielle M McCarthy; Laura M Curtis; D Mark Courtney; Kenzie A Cameron; Patrick M Lank; Howard S Kim; Lauren A Opsasnick; Abbie E Lyden; Stephanie J Gravenor; Andrea M Russell; Morgan R Eifler; Scott I Hur; Megan E Rowland; Surrey M Walton; Enid Montague; Kwang-Youn A Kim; Michael S Wolf
Journal:  Acad Emerg Med       Date:  2019-11-19       Impact factor: 3.451

6.  Health IT Usability Focus Section: Adapting EHR-Based Medication Instructions to Comply with Plain Language Guidance-A Randomized Experiment.

Authors:  Jessica S Ancker; Alexander Send; Baria Hafeez; Snezana N Osorio; Erika Abramson
Journal:  Appl Clin Inform       Date:  2017-12-14       Impact factor: 2.342

Review 7.  Methodological review: quality of randomized controlled trials in health literacy.

Authors:  Julii Brainard; Stephanie Howard Wilsher; Charlotte Salter; Yoon Kong Loke
Journal:  BMC Health Serv Res       Date:  2016-07-11       Impact factor: 2.655

8.  Electronic Health Record-Based Strategy to Promote Medication Adherence Among Patients With Diabetes: Longitudinal Observational Study.

Authors:  Stacy Cooper Bailey; Amisha Wallia; Sarah Wright; Guisselle A Wismer; Alexandra C Infanzon; Laura M Curtis; Samantha A Brokenshire; Arlene E Chung; Daniel S Reuland; Allison J Hahr; Kenneth Hornbuckle; Karen Lockwood; Lori Hall; Michael S Wolf
Journal:  J Med Internet Res       Date:  2019-10-21       Impact factor: 5.428

9.  Advancing the field of pharmaceutical risk minimization through application of implementation science best practices.

Authors:  Meredith Y Smith; Elaine Morrato
Journal:  Drug Saf       Date:  2014-08       Impact factor: 5.606

Review 10.  A Scoping Review on How to Make Hospitals health Literate Healthcare Organizations.

Authors:  Patrizio Zanobini; Chiara Lorini; Alberto Baldasseroni; Claudia Dellisanti; Guglielmo Bonaccorsi
Journal:  Int J Environ Res Public Health       Date:  2020-02-06       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.